Abstract

Objectives: Our aim is investigating the predictive potential of these available and convenient laboratory dates in stage IV colorectal cancer (CRC) patients. Methods: We identified the cases of 114 consecutive patients who underwent the surgery at our Hospital between January 2006 and December 2012 by using the multivariate analysis, the Cox proportional-hazard regression model. Results: Multivariate analysis for the predictors of survival showed metastatic lesion resection [hazard ratio (HR) = 3.2, 95% confidence interval (CI) 1.6 - 6.6; p = 0.007] and only primary lesion resection (HR = 1.9, 95% CI 1.1 - 4.0; p = 0.045) remained independently significant prognostic factors. Therefore, we divided in 3 groups, 1) metastatic lesion resection group with primary lesion resection (n = 52 in the Met/Prim lesion group), 2) primary lesion resection without metastatic lesion resection (n = 38 in the Primary lesion group) and 3) palliative operation (n = 24 in the Palliative group). Age was the only independent risk factor in the Met/Prim lesion group. In the Primary lesion group, Neutrophil lymphocyte ratio (NLR) > 5, elevated Alanine aminotransferase and patients without chemotherapy were correlated with poor survival. In the Palliative group, NLR > 5 and patients who could not be treated with chemotherapy remained independent predictors of worse survival. Conclusions: NLR is not only simple and convenient for classification of patients, but also one of the important predictors of mortality for stage IV incurable CRC patients.

Highlights

  • Most of the surgeons have concluded that metastatic lesion resection is feasible and improves the survival of patients with resectable stage IV colorectal cancer (CRC) [18]

  • There is controversy regarding whether a primary resection should be undertaken in incurable stage 4 CRC patients

  • A primary resection does ensure that the primary cancer is removed, preventing perforation and stenosis and improving the likelihood of survival, as we found in the present study

Read more

Summary

Introduction

Several promising candidate markers have been reported to have potential usefulness in the prediction of radiation and chemotherapy responses among CRC patients, including metabolic enzymes (thymidine phosphorylase, thymidylate synthase), angiogenesis (vascular endothelial growth factor), apoptosis (bax, p 53, nuclear factor-kappa B, and survivin), inflammation (cyclooxygenase-2, interleukin [IL]-6, IL-10, C-reactive protein concentration [CRP]), proliferation (proliferating cell nuclear antigen), and cell adhesion or collagenase (CD44, CD133, matrix metalloproteinase [MMP] 2, and MMP9) [2] [3] [4] [5]. Genetic biomarkers such as microsatellite instability, CpG island methylator phenotype, and chromosomal instability have been reported to be valid indicators of poor prognosis in CRC [6]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call